Tim Petersen joined Arboretum Ventures as a Managing Director in 2002. His investments primarily target capital-efficient health IT and services companies that redefine efficient models for care delivery and improving access to care. Tim has led investments and held board seats for Arboretum in more than a dozen companies, including HealthMedia (acquired by J&J in 2008 for $175 million), Accuri Cytometers (acquired by Becton Dickinson in 2011 for $205 million) and Inogen (IPO in 2014). Tim currently serves on the boards of Advanced ICU Care, KFx, Inogen, Cervilenz, MyHealthDirect, Tangent, Fidelis, and IntelliCyt.
From 1999 to 2002, Tim worked for the Zell Lurie Institute for Entrepreneurial Studies at the University of Michigan, serving as its Managing Director. During his tenure at Michigan, he also directed the activities of the Wolverine Venture Fund, the Institute's venture fund focused on early-stage life science and technology investments. Prior to Michigan, Tim was a manager in the investment banking practice at Plante Moran Corporate Finance and served as a management consultant at Industrial Economics, Inc.
Tim is involved in a number of community efforts focused on venture capital and entrepreneurship and has served as Chairman of the Michigan Venture Capital Association.
Tim holds a BA in Economics from Williams College, an MS in Economics from the University of Wisconsin-Madison, and an MBA from the Ross School of Business at the University of Michigan.